Healthcare - Biotechnology - NASDAQ - US
$ 0.1
-9.09 %
$ 1.09 M
Market Cap
-0.04
P/E
CASH FLOW STATEMENT
-10.8 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
13.6 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
PaxMedica, Inc. Common Stock
| Net Income | -18.3 M |
| Depreciation & Amortization | 168 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 5.2 B |
| Change in Working Capital | 334 K |
| Others | -5.2 B |
| Free Cash Flow | -10.8 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (18.3) | (14.8) | (10.2) | (7.8) | (0.6) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 5 204.9 | 4.4 | 1.3 | 2.3 | 0 |
| Other Operating Activities | (5 197.8) | 4.3 | 3.0 | 2.3 | 62.6 K |
| Change in Working Capital | 0.3 | 50.3 K | 0.4 | 1.0 | 0.1 |
| Cash From Operations | (10.8) | (6.1) | (5.5) | (2.3) | (0.4) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | (0.2) | 35 K | 0 | 0 | 0 |
| Total Debt Repaid | 2.5 | 1.2 | 0 | 2.9 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.6) | 0.3 | (0.2) | 0.5 | 0.4 |
| Cash From Financing Activities | 13.6 | 7.5 | 4.8 | 3.4 | 0.4 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 2.8 | 1.5 | (0.7) | 1.1 | 15.6 K |
| FREE CASH FLOW | |||||
| Free Cash Flow | (10.8) | (6.1) | (5.5) | (2.3) | (0.4) |